Pieter Jelle Visser
Pieter Jelle Visser
Maastricht University and VU University Medical Centre
Verified email at vumc.nl
Title
Cited by
Cited by
Year
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
B Dubois, HH Feldman, C Jacova, ST DeKosky, P Barberger-Gateau, ...
The Lancet Neurology 6 (8), 734-746, 2007
45792007
Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
B Winblad, K Palmer, M Kivipelto, V Jelic, L Fratiglioni, LO Wahlund, ...
Journal of internal medicine 256 (3), 240-246, 2004
45502004
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ...
The Lancet Neurology 13 (6), 614-629, 2014
22972014
Revising the definition of Alzheimer's disease: a new lexicon
B Dubois, HH Feldman, C Jacova, JL Cummings, ST DeKosky, ...
The Lancet Neurology 9 (11), 1118-1127, 2010
20292010
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
F Jessen, RE Amariglio, M Van Boxtel, M Breteler, M Ceccaldi, G Chételat, ...
Alzheimer's & dementia 10 (6), 844-852, 2014
12312014
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ...
Jama 302 (4), 385-393, 2009
12042009
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
8912015
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium …
F Portet, PJ Ousset, PJ Visser, GB Frisoni, F Nobili, P Scheltens, B Vellas, ...
Journal of Neurology, Neurosurgery & Psychiatry 77 (6), 714-718, 2006
7262006
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA …
PJ Visser, F Verhey, DL Knol, P Scheltens, LO Wahlund, Y Freund-Levi, ...
The Lancet Neurology 8 (7), 619-627, 2009
5992009
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease
GB Karas, P Scheltens, S Rombouts, PJ Visser, RA Van Schijndel, ...
Neuroimage 23 (2), 708-716, 2004
5992004
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
SJB Vos, C Xiong, PJ Visser, MS Jasielec, J Hassenstab, EA Grant, ...
The Lancet Neurology 12 (10), 957-965, 2013
4752013
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment
ESC Korf, LO Wahlund, PJ Visser, P Scheltens
Neurology 63 (1), 94-100, 2004
3942004
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis
R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ...
Jama 313 (19), 1939-1950, 2015
3922015
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment
PJ Visser, FRJ Verhey, PAM Hofman, P Scheltens, J Jolles
Journal of Neurology, Neurosurgery & Psychiatry 72 (4), 491-497, 2002
3882002
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment
PJ Visser, P Scheltens, FRJ Verhey, B Schmand, LJ Launer, J Jolles, ...
Journal of neurology 246 (6), 477-485, 1999
3671999
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ...
The Lancet Neurology 16 (8), 661-676, 2017
3032017
Optimizing patient care and research: the Amsterdam Dementia Cohort
WM van der Flier, YAL Pijnenburg, N Prins, AW Lemstra, FH Bouwman, ...
Journal of Alzheimer's disease 41 (1), 313-327, 2014
2772014
Epigenetic regulation in the pathophysiology of Alzheimer's disease
L Chouliaras, BPF Rutten, G Kenis, O Peerbooms, PJ Visser, F Verhey, ...
Progress in neurobiology 90 (4), 498-510, 2010
2612010
Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ...
Biomarkers in medicine 6 (4), 419-430, 2012
2432012
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ...
Brain 138 (5), 1327-1338, 2015
2412015
The system can't perform the operation now. Try again later.
Articles 1–20